Skip to content

WORLD LEADING HEALTH EXPERT URGES AUSTRALIAN GOVERNMENT TO INVEST IN TECHNOLOGIES THAT PROMOTE SAFER PREGNANCIES

By API User

Esteemed Professor Helen Murphy is visiting Australia from 13 to 24 October 2025 drawing on her decades of research to advocate for safer pregnancy outcomes for Australian women with type 1 diabetes, using cutting-edge technology. Prof Murphy has championed the ‘artificial pancreas’ in the UK which is credited with transforming health outcomes for pregnant women … Continued

Study reveals significant increase in diagnosis of endometriosis in women attending Australian general practice

By API User

The proportion of women presenting to Australian general practice with endometriosis almost doubled between 2011‒2021, according to a new study by Monash University’s SPHERE Centre of Research Excellence. The comprehensive cohort study, The clinical presentation, investigation, and management of women diagnosed with endometriosis in Australian general practices, 2011–2021: an open cohort study, was published this … Continued

KFSHRC Performs World’s First Robotic Intracranial Tumor Resection … A New Era in Neurosurgery

By API User

RIYADH, Saudi Arabia, Oct. 20, 2025 (GLOBE NEWSWIRE) — In a historic leap for robotic medicine, King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first robotic intracranial tumor resection, a groundbreaking achievement that sets a new global standard in neurosurgical precision and recovery. The surgery was conducted on … Continued

BeOne Medicines Presents New Data on TEVIMBRA in Lung Cancer at ESMO 2025

By API User

New data from two pivotal TEVIMBRA studies – RATIONALE-307 and -312 – reinforce the PD-1 inhibitor’s proven clinical benefit in both NSCLC and ES-SCLC Early data from investigational HPK1 inhibitor BGB-26808, in combination with TEVIMBRA, show promise in advanced solid tumors SAN CARLOS, Calif.–BUSINESS WIRE– BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a … Continued

Iksuda Presents Encouraging IKS014 Phase 1 Data at ESMO

By API User

New safety, efficacy and pharmacokinetic results presented from dose escalation portion of the study Anti-tumour activity observed across all dose levels and in various tumour indications NEWCASTLE, England–BUSINESS WIRE– Iksuda Therapeutics (Iksuda), the developer of class leading, antibody drug conjugates (ADCs), today announces the presentation of new data from its Phase 1 study of IKS014, … Continued

Vale Professor John Murtagh: A giant of Australian general practice

By API User

he general practice profession is in mourning following the passing of Emeritus Professor John Murtagh AO.  He passed away peacefully at the Alfred Hospital in Melbourne, surrounded by members of his loving family. He was 89.  Royal Australian College of GPs (RACGP) President Dr Michael Wright described Professor Murtagh as a towering figure in general … Continued

Global study revises greenhouse gas emissions for tropical inland waters

By API User

Tropical inland waters don’t produce as many greenhouse gas (GHG) emissions as previously estimated, according to the results of an international research collaboration led by Charles Darwin University (CDU). The study, published in Nature Water, aimed to better understand GHG emissions in tropical rivers, lakes and reservoirs by collating the growing number of observations from … Continued

Monash scientists uncover genetic code that could unlock game-changing mRNA disease therapies

By API User

Key points  Monash researchers have uncovered the hidden ‘code’ governing how genetic mutations affect RNA splicing and result in disease Breakthrough paves the way for treatment and even cures for diseases, including population-specific and rare diseases Scientists expected to begin using discovery to develop new treatments based on RNA therapeutics An international team led by Monash … Continued